Secukinumab, a human anti-IL-17A monoclonal antibody, for moderate to severe Crohn's disease: unexpected results of a randomised, double-blind plac... - PubMed - NCBI

  • 1


    Mendeley users who have this article in their library.
  • N/A


    Citations of this article.

Author-supplied keywords

  • Adolescent
  • Adult
  • Aged
  • Anti-Inflammatory Agents
  • Antibodies
  • Bayes Theorem
  • Biomarkers
  • Crohn Disease
  • Double-Blind Method
  • Drug Administration Schedule
  • Female
  • Genetic Markers
  • Humans
  • Infusions
  • Interleukin-17
  • Intravenous
  • Leukocyte L1 Antigen Complex
  • Male
  • Middle Aged
  • Monoclonal
  • Polymorphism
  • Severity of Illness Index
  • Single Nucleotide
  • Treatment Failure
  • Young Adult

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

There are no full text links

There are no authors.

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free